EGFR-targeting antitumor therapy: Neuregulins or antibodies?

1. de Lavera, I.
2. Merkling, P.J.
3. Oliva, J.M.
4. Sayagués, M.J.
5. Cotán, D.
6. Sánchez-Alcázar, J.A.
7. Infante, J.J.
8. Zaderenko, A.P.